Imipramine for the treatment of fibrositis: a therapeutic trial.

AUTOR(ES)

Wysenbeek, A J

RESUMO

Twenty fibrositic patients were treated with imipramine 50-75 mg/day. Only two patients responded favourably. Nineteen patients stopped therapy during the initial three-month period: 14 of them due to lack of response, while two of these concomitantly disclosed side effects. The additional five patients stopped therapy mainly due to side effects, while only one of them improved with therapy. One patient, only, improved and adhered to therapy for more than three months.

Documentos Relacionados

• Aetiology of Fibrositis: A Review
• Fibrositis: Some Old and New Points of View
• The Nature of Fibrositis: II. A Study of the Causation of the Myalgic Lesion
• The Nature of Fibrositis: III. Multiple Lesions and the Neural Hypothesis *
• The Nature of Fibrositis: I. The Myalgic Lesion and its Secondary Effects: a Reflex Theory